Growth Hormone Axis Education Protocol

๐Ÿ“š Foundation Education Protocol

Back to Library
๐Ÿ“š

Foundation Education

Growth Hormone Axis Education Protocol

Comprehensive educational overview of the GH/IGF-1 axis for clinician discussion

Moderate Risk ProfilebeginnerModerate EvidenceNeeds clinician review
Important Notice

โ€ข This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.

โ€ข All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.

โ€ข Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.

โ€ข Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.

Find a licensed clinician

Overview

A foundational educational protocol explaining how the growth hormone axis works, what research compounds interact with it, and what questions to bring to an endocrinologist.

Mechanism Summary

The GH axis involves hypothalamic GHRH โ†’ anterior pituitary GH release โ†’ liver IGF-1 production. Secretagogues can stimulate this axis through GHRH receptor or ghrelin receptor pathways. Downstream effects include metabolism, body composition, tissue repair, and aging-related changes.

Intended Goal

Build foundational understanding of GH axis before clinical consultation

Compounds listed below are referenced in an educational catalog context only. No specific use is implied.

CJC-1295

Calculate

Research category: GH secretagogue / GHRH analogue

Long-acting GHRH analogue. Often studied with a ghrelin mimetic. Catalog reference.

Sermorelin

Calculate

Research category: GH secretagogue / GHRH analogue

Short-acting GHRH analogue with established clinical use context. Catalog reference.

Ipamorelin

Calculate

Research category: GH secretagogue / ghrelin mimetic

Selective ghrelin receptor agonist. Frequently paired with CJC-1295. Catalog reference.

GHRP-2

Calculate

Research category: GH secretagogue / ghrelin mimetic

Potent ghrelin receptor agonist. Higher GH pulse amplitude than Ipamorelin. Catalog reference.

Who may be a candidate

  • โœ“Adults exploring GH axis options with their endocrinologist
  • โœ“Individuals with clinician-diagnosed GH deficiency

Exclusions

  • โœ•Not for individuals seeking self-directed GH optimization without clinical evaluation
1

Do I have documented GH deficiency?

2

What should my target IGF-1 range be for my age?

3

How often would you check my labs?

4

What are the cancer risk considerations given my history?

Print or copy these questions using the "Copy Summary" button to bring to your appointment.

Legal & Compliance Notice

Some GH secretagogues are prescription-only; others are research compounds. Status varies significantly by jurisdiction and compound.

The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.

This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.

Last reviewed: 2025-01-15 ยท Status: clinician-reviewed

Talk to a Licensed Clinician

The information in this protocol is for educational reference only. Before considering any compound, schedule a consultation with a qualified healthcare professional who can review your personal health history, order appropriate labs, and provide personalized guidance.

Bring this protocol to your appointmentReview clinician questions below